• RBC Capital Markets forecasts NVIDIA (NVDA) will exceed earnings expectations by 3-4% in its upcoming quarterly report.
  • The firm maintains an Outperform rating and $240 price target, citing NVIDIA's $500 billion+ backlog for 2025-2026 and resilient gross margins.
  • Key catalysts include Blackwell-related launches and GTC, with supply-chain checks indicating robust growth for the Rubin platform into 2027.

NVIDIA Poised for Another Strong Quarter

RBC Capital Markets has reiterated its confidence in NVIDIA, expecting the semiconductor giant to deliver another earnings beat when it reports quarterly results. Analyst Srini Pajjuri anticipates a 3-4% upside relative to consensus estimates, with management likely to emphasize the company's previously cited $500 billion+ backlog for 2025-2026. According to people familiar with the matter, supply-chain checks suggest robust growth for the Rubin platform extending well into 2027, providing visibility beyond current forecasts.

Gross margins are seen as resilient despite rising memory prices, as 2026 HBM pricing is believed to be locked in through existing agreements. This pricing stability comes at a critical time, with memory costs increasing across the industry. NVIDIA's inventory and purchase commitments jumped $25 billion in the most recent quarter, signaling strong demand that should translate into revenue growth over subsequent periods. CFO Colette Kress confirmed that all inventory at the start of December had already shipped to customers, underscoring the tight supply-demand dynamics.

Strategic Positioning and Market Valuation

NVIDIA currently trades at a double-digit discount to semiconductor peers and the "Magnificent Seven" technology stocks, with valuations around 24x forward earnings. This discount persists despite the company's dominant position in AI infrastructure and expanding product pipeline. The $240 price target represents approximately 31% upside from recent trading levels around $183-$187 per share, reflecting RBC's view that the market is underestimating NVIDIA's ability to sustain its AI leadership through 2026 and beyond.

Upcoming catalysts include Blackwell-related product launches and NVIDIA's GPU Technology Conference (GTC), where the company typically makes significant announcements about its technology roadmap. The Vera Rubin GPU platform is already in production for second-half 2026 shipment, according to industry sources, providing a clear growth runway. Meanwhile, China opportunities remain excluded from current estimates, representing potential additional upside should regulatory conditions evolve favorably.

Competitive Landscape and Execution Risks

While competition from alternative silicon and AMD (AMD) continues to intensify, NVIDIA maintains advantages through its full-stack performance leadership and comprehensive ecosystem. The company's expansion into physical AI, robotics platforms, and foundation models opens new market categories beyond traditional data center infrastructure. However, recent developments present mixed signals—U.S. regulations have eased restrictions on exporting the H200 chip to China, but China has simultaneously tightened restrictions on chip purchases for most applications.

Efforts to maintain growth momentum face challenges from potential hyperscaler capital expenditure slowdowns, though RBC believes any pullback would be gradual and manageable. The firm's analysis suggests that NVIDIA's enterprise partnerships, including a $1 billion, five-year investment with Eli Lilly (LLY) focused on drug discovery using the BioNeMo platform, provide diversified revenue streams beyond cloud infrastructure. As one industry executive noted, "The market here is not as competitive as other markets—you can create your own ideas."

NVIDIA did not immediately respond to requests for comment on the RBC analysis or specific financial projections. The company's next earnings report will provide crucial validation of whether current execution matches the ambitious growth expectations embedded in analyst forecasts.